Histone deacetylase co-repressor complex control of Runx2 and bone formation

Aswathy K. Nair, Eric D. Jensen, Jennifer J Westendorf

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

A decade has passed since the transcription factor, Runx2, was found to be essential for osteoblast development and chondrocyte hypertrophy. During the last 10 years, our understanding of Runx2's physiological roles and the molecular mechanisms whereby it regulates gene expression to control cell-cycle progression and cellular differentiation has increased exponentially. Runx2 is expressed in osteoblasts, prehypertrophic chondrocytes, mesenchymal cells of the perichondrium, T lymphocytes, endothelial cells, and breast and prostate epithelial cells, with increased expression observed in breast and prostate carcinomas. Although Runx2 and other mammalian Runt domain proteins were originally described as transcriptional activators, they are also transcriptional repressors and thus maintain functional similarities with their Drosophila homolog, Runt. Runx2 binds a consensus DNA sequence but does not possess any enzymatic activities that directly affect chromatin structure. It alters gene expression by recruiting cofactors to gene regulatory elements. Histone deacetylases (HDACs) are among the co-repressors that interact with Runx2. In this review, we summarize data demonstrating that several HDACs and their associated proteins interact with Runx2, regulate its activity, and affect bone formation. HDACs are components of multiprotein complexes that interact with many transcription factors and are subject to regulation by extracellular signals. The elucidation of HDAC complex components that influence Runx2 activity in specific cell types and in response to various extracellular stimuli will increase our understanding of how this crucial transcription factor functions, and how we might be able to control its activity to influence bone formation or reduce bone disease associated with cancer metastasis.

Original languageEnglish (US)
Pages (from-to)187-196
Number of pages10
JournalCritical Reviews in Eukaryotic Gene Expression
Volume17
Issue number3
StatePublished - 2007

Fingerprint

Co-Repressor Proteins
Histone Deacetylases
Osteogenesis
Transcription Factors
Chondrocytes
Osteoblasts
Prostate
Gene Expression
Multiprotein Complexes
Bone Diseases
Consensus Sequence
Regulator Genes
Cell Cycle Checkpoints
Hypertrophy
Drosophila
Chromatin
Breast
Endothelial Cells
Epithelial Cells
Breast Neoplasms

Keywords

  • AML-3
  • Cbfa1
  • HDAC
  • HDAC inhibitors
  • Osteoblasts
  • PEBP2aA

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Histone deacetylase co-repressor complex control of Runx2 and bone formation. / Nair, Aswathy K.; Jensen, Eric D.; Westendorf, Jennifer J.

In: Critical Reviews in Eukaryotic Gene Expression, Vol. 17, No. 3, 2007, p. 187-196.

Research output: Contribution to journalArticle

@article{f1808468d8ac4fab8ba9b4c4f6a8a27b,
title = "Histone deacetylase co-repressor complex control of Runx2 and bone formation",
abstract = "A decade has passed since the transcription factor, Runx2, was found to be essential for osteoblast development and chondrocyte hypertrophy. During the last 10 years, our understanding of Runx2's physiological roles and the molecular mechanisms whereby it regulates gene expression to control cell-cycle progression and cellular differentiation has increased exponentially. Runx2 is expressed in osteoblasts, prehypertrophic chondrocytes, mesenchymal cells of the perichondrium, T lymphocytes, endothelial cells, and breast and prostate epithelial cells, with increased expression observed in breast and prostate carcinomas. Although Runx2 and other mammalian Runt domain proteins were originally described as transcriptional activators, they are also transcriptional repressors and thus maintain functional similarities with their Drosophila homolog, Runt. Runx2 binds a consensus DNA sequence but does not possess any enzymatic activities that directly affect chromatin structure. It alters gene expression by recruiting cofactors to gene regulatory elements. Histone deacetylases (HDACs) are among the co-repressors that interact with Runx2. In this review, we summarize data demonstrating that several HDACs and their associated proteins interact with Runx2, regulate its activity, and affect bone formation. HDACs are components of multiprotein complexes that interact with many transcription factors and are subject to regulation by extracellular signals. The elucidation of HDAC complex components that influence Runx2 activity in specific cell types and in response to various extracellular stimuli will increase our understanding of how this crucial transcription factor functions, and how we might be able to control its activity to influence bone formation or reduce bone disease associated with cancer metastasis.",
keywords = "AML-3, Cbfa1, HDAC, HDAC inhibitors, Osteoblasts, PEBP2aA",
author = "Nair, {Aswathy K.} and Jensen, {Eric D.} and Westendorf, {Jennifer J}",
year = "2007",
language = "English (US)",
volume = "17",
pages = "187--196",
journal = "Critical Reviews in Eukaryotic Gene Expression",
issn = "1045-4403",
publisher = "Begell House Inc.",
number = "3",

}

TY - JOUR

T1 - Histone deacetylase co-repressor complex control of Runx2 and bone formation

AU - Nair, Aswathy K.

AU - Jensen, Eric D.

AU - Westendorf, Jennifer J

PY - 2007

Y1 - 2007

N2 - A decade has passed since the transcription factor, Runx2, was found to be essential for osteoblast development and chondrocyte hypertrophy. During the last 10 years, our understanding of Runx2's physiological roles and the molecular mechanisms whereby it regulates gene expression to control cell-cycle progression and cellular differentiation has increased exponentially. Runx2 is expressed in osteoblasts, prehypertrophic chondrocytes, mesenchymal cells of the perichondrium, T lymphocytes, endothelial cells, and breast and prostate epithelial cells, with increased expression observed in breast and prostate carcinomas. Although Runx2 and other mammalian Runt domain proteins were originally described as transcriptional activators, they are also transcriptional repressors and thus maintain functional similarities with their Drosophila homolog, Runt. Runx2 binds a consensus DNA sequence but does not possess any enzymatic activities that directly affect chromatin structure. It alters gene expression by recruiting cofactors to gene regulatory elements. Histone deacetylases (HDACs) are among the co-repressors that interact with Runx2. In this review, we summarize data demonstrating that several HDACs and their associated proteins interact with Runx2, regulate its activity, and affect bone formation. HDACs are components of multiprotein complexes that interact with many transcription factors and are subject to regulation by extracellular signals. The elucidation of HDAC complex components that influence Runx2 activity in specific cell types and in response to various extracellular stimuli will increase our understanding of how this crucial transcription factor functions, and how we might be able to control its activity to influence bone formation or reduce bone disease associated with cancer metastasis.

AB - A decade has passed since the transcription factor, Runx2, was found to be essential for osteoblast development and chondrocyte hypertrophy. During the last 10 years, our understanding of Runx2's physiological roles and the molecular mechanisms whereby it regulates gene expression to control cell-cycle progression and cellular differentiation has increased exponentially. Runx2 is expressed in osteoblasts, prehypertrophic chondrocytes, mesenchymal cells of the perichondrium, T lymphocytes, endothelial cells, and breast and prostate epithelial cells, with increased expression observed in breast and prostate carcinomas. Although Runx2 and other mammalian Runt domain proteins were originally described as transcriptional activators, they are also transcriptional repressors and thus maintain functional similarities with their Drosophila homolog, Runt. Runx2 binds a consensus DNA sequence but does not possess any enzymatic activities that directly affect chromatin structure. It alters gene expression by recruiting cofactors to gene regulatory elements. Histone deacetylases (HDACs) are among the co-repressors that interact with Runx2. In this review, we summarize data demonstrating that several HDACs and their associated proteins interact with Runx2, regulate its activity, and affect bone formation. HDACs are components of multiprotein complexes that interact with many transcription factors and are subject to regulation by extracellular signals. The elucidation of HDAC complex components that influence Runx2 activity in specific cell types and in response to various extracellular stimuli will increase our understanding of how this crucial transcription factor functions, and how we might be able to control its activity to influence bone formation or reduce bone disease associated with cancer metastasis.

KW - AML-3

KW - Cbfa1

KW - HDAC

KW - HDAC inhibitors

KW - Osteoblasts

KW - PEBP2aA

UR - http://www.scopus.com/inward/record.url?scp=34249994607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249994607&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 187

EP - 196

JO - Critical Reviews in Eukaryotic Gene Expression

JF - Critical Reviews in Eukaryotic Gene Expression

SN - 1045-4403

IS - 3

ER -